Long-term outcomes of atezolizumab–bevacizumab in unresectable hepatocellular carcinoma: A real-world study

20260 citationsJournal Article

Authors

Francesco Tovoli · Azienda USL di Bologna

Massimo Iavarone · University of Milan

Giuseppe Cabibbo · Department of Health

F. Marra · University of Florence

Caterina Vivaldi · Azienda Ospedaliera Universitaria Pisana

Andrea Dalbeni · University of Verona

Francesca Romana Ponziani ·

Abstract

Our data confirmed the sustained effectiveness of AB without new safety concerns. Surgical/locoregional treatments after the start of AB and liver decompensation were common, highlighting the need for a multidisciplinary and integrated approach in advanced HCC.

Topics & Keywords

Hepatocellular Carcinoma Treatment and Prognosis Colorectal Cancer Treatments and Studies Cholangiocarcinoma and Gallbladder Cancer Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Hepatology

DOI: 10.1097/hep.0000000000001725

Field-Weighted Citation Impact: 0.00